BCV
GTHX

Banque Cantonale Vaudoise’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Banque Cantonale Vaudoise’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,500
Closed -$33K – 1371
2021
Q2 		$33K Hold
1,500
– – ﹤0.01% 1104
2021
Q1 		$36K Buy
+1,500
New +$34.9K ﹤0.01% 1024

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Banque Cantonale Vaudoise's GTHX Position: Q3 2021 in Review

Banque Cantonale Vaudoise sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2021, closing a stake of 1,500 shares — an estimated $33K sold.

Banque Cantonale Vaudoise first reported a position in GTHX in Q1 2021 and held it in 2 quarters. The position peaked at $36K in Q1 2021. 115 funds tracked by Wall St. Rank hold GTHX as of Q3 2021.

  • Banque Cantonale Vaudoise reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,500 G1 Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $33K.
  • Banque Cantonale Vaudoise first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Banque Cantonale Vaudoise's G1 Therapeutics, Inc. Common Stock position peaked at $36K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2021, filed 29 Oct 2021.